We confirmed it as a biomarker of M2 macrophage infiltration in various cancers and speculated that JMJD8 mediated the CSC immunity surveillance, M2 macrophage polarization, and CD8+ T-cell depression induced by CD276. The gene discussed is CD8A; the disease is cancer.